Bilthoven -Model IPV -Inactivated Poliomyelitis Vaccine
Bilthoven Biologicals produces IPV, which is an inactivated polio vaccine. Among other uses, this vaccine is used for the global polio eradication program (GPEI). For IPV vaccine, we use inactivated (dead) polio virus. After vaccination, the inactivated virus triggers an immune response, but can no longer cause the disease itself.
Globally, vaccination is also done with an oral polio vaccine. The vaccine is often ingested after applying a few drops onto a lump of sugar. This oral vaccine is comprised of a virus in its weakened state. In some cases, the weakened virus can mutate and cause polio in a vaccinated person.
Report side effects
This is how we contribute to the eradication of polio
Polio – also known as child paralysis – is a serious disease that can result in paralysis of all muscles. The polio virus spreads with relative ease and can result in epidemics. Since the end of the 1950’s, polio vaccine is added to The Dutch Vaccination Programme in the form of a DTP vaccination. Nevertheless, we still counted 71 cases of polio in 1992. In 1988, WHO started a vaccination programme to eradicate polio globally. This programme, vaccinating 60 million people a year, is carried out by UNICEF. Half of these vaccines are supplied by Bilthoven Biologicals.